Role of neutral ceramidase in colon cancer

FASEB Journal

Volumn 30, Issue 12, 2016, Pages 4159-4171

  García Barros, Mónica ^a,b   Coant, Nicolas ^a,b   Kawamori, Toshihiko ^c,d   Wada, Masayuki ^a,b   Snider, Ashley J ^a,b,e   Truman, Jean Philip ^a,b   Wu, Bill X ^f   Furuya, Hideki ^b   Clarke, Christopher J ^a,b   Bialkowska, Agnieszka B ^a   Ghaleb, Amr ^a   Yang, Vincent W ^a   Obeid, Lina M ^a,b,e   Hannun, Yusuf A ^a,b,g  

^a STONY BROOK UNIVERSITY   (United States)

^b Stony Brook Medicine   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^d Research Institute for Cancer Prevention and Pathologic Diagnosis   (Japan)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g STONY BROOK UNIVERSITY   (United States)

Author keywords

Aberrant crypt foci; Apoptosis; Azoxymethane; Sphingolipids ceramide

Indexed keywords

AZOXYMETHANE; BETA CATENIN; C 6 UREA CERAMIDE; CERAMIDE; CERAMIDE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRAL CERAMIDASE; UNCLASSIFIED DRUG; UREA DERIVATIVE; SPHINGOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; CELL SURVIVAL; CHEMOPROPHYLAXIS; COLON ADENOCARCINOMA; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; GENE LOSS; HCT 116 CELL LINE; HT-29 CELL LINE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; COLON; COLON TUMOR; ENZYMOLOGY; KNOCKOUT MOUSE; LIPID METABOLISM; METABOLISM; PHYSIOLOGY;

ANIMALS; BETA CATENIN; CERAMIDES; COLON; COLONIC NEOPLASMS; HUMANS; LIPID METABOLISM; MALE; MICE, KNOCKOUT; NEUTRAL CERAMIDASE; SPHINGOLIPIDS;

EID: 85002213807     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.201600611R     Document Type: Article

References (64)

1. Vogelstein, B., Fearon, E. R., Hamilton, S.R., Kern, S. E., Preisinger, A.C., Leppert, M., Nakamura, Y., White, R., Smits, A.M., and Bos, J. L. (1988) Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525-532
2. Arnold, C. N., Goel, A., Blum, H. E., and Boland, C. R. (2005) Molecular pathogenesis of colorectal cancer: implications for molecular diagnosis. Cancer 104, 2035-2047
3. Hannun, Y. A., and Obeid, L.M. (2011) Many ceramides. J. Biol. Chem. 286, 27855-27862
4. Hannun, Y. A. (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855-1859
5. Nikolova-Karakashian, M. N., and Rozenova, K. A. (2010) Ceramide in stress response. Adv. Exp. Med. Biol. 688, 86-108
6. Stancevic, B., and Kolesnick, R. (2010) Ceramide-rich platforms in transmembrane signaling. FEBS Lett. 584, 1728-1740
7. El Alwani, M., Wu, B. X., Obeid, L. M., and Hannun, Y. A. (2006) Bioactive sphingolipids in the modulation of the inflammatory response. Pharmacol. Ther. 112, 171-183
8. Kawamori, T., Osta, W., Johnson, K. R., Pettus, B. J., Bielawski, J., Tanaka, T., Wargovich, M. J., Reddy, B. S., Hannun, Y. A., Obeid, L. M., and Zhou, D. (2006) Sphingosine kinase 1 is up-regulated in colon carcinogenesis. FASEB J. 20, 386-388
9. Kawamori, T., Kaneshiro, T., Okumura, M., Maalouf, S., Uflacker, A., Bielawski, J., Hannun, Y. A., and Obeid, L. M. (2009) Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 23, 405-414
10. Tan, S. S., Khin, L. W., Wong, L., Yan, B., Ong, C. W., Datta, A., Salto-Tellez, M., Lam, Y., and Yap, C. T. (2014) Sphingosine kinase 1 promotes malignant progression in colon cancer and independently predicts survival of patients with colon cancer by competing risk approach in South Asian population. Clin. Transl. Gastroenterol. 5, e51
11. Oskouian, B., and Saba, J. (2007) Sphingosine-1-phosphate metabolism and intestinal tumorigenesis: lipid signaling strikes again. Cell Cycle 6, 522-527
12. Hertervig, E., Nilsson, A., Nyberg, L., and Duan, R. D. (1997) Alkaline sphingomyelinase activity is decreased in human colorectal carcinoma. Cancer 79, 448-453
13. Dillehay, D. L., Webb, S. K., Schmelz, E. M., and Merrill, A. H., Jr. (1994) Dietary sphingomyelin inhibits 1,2-dimethylhydrazine-induced colon cancer in CF1 mice. J. Nutr. 124, 615-620
14. Schmelz, E.M., Dillehay, D. L., Webb, S. K., Reiter, A., Adams, J., and Merrill, A. H., Jr. (1996) Sphingomyelin consumption suppresses aberrant colonic crypt foci and increases the proportion of adenomas versus adenocarcinomas in CF1 mice treatedwith 1,2-dimethylhydrazine: implications for dietary sphingolipids and colon carcinogenesis. Cancer Res. 56, 4936-4941
15. Symolon, H., Bushnev, A., Peng, Q., Ramaraju, H., Mays, S. G., Allegood, J. C., Pruett, S. T., Sullards, M. C., Dillehay, D. L., Liotta, D. C., and Merrill, A. H., Jr. (2011) Enigmol: a novel sphingolipid analogue with anticancer activity against cancer cell lines and in vivo models for intestinal and prostate cancer. Mol. Cancer Ther. 10, 648-657
16. García-Barros, M., Coant, N., Truman, J.P., Snider, A. J., and Hannun, Y. A. (2014) Sphingolipids in colon cancer. Biochim. Biophys. Acta 1841, 773-782
17. Ito, M., Okino, N., and Tani, M. (2014) New insight into the structure, reaction mechanism, and biological functions of neutral ceramidase. Biochim. Biophys. Acta 1841, 682-691
18. Novgorodov, S. A., Wu, B. X., Gudz, T. I., Bielawski, J., Ovchinnikova, T. V., Hannun, Y. A., and Obeid, L. M. (2011) Novel pathway of ceramide production in mitochondria: thioesterase and neutral ceramidase produce ceramide fromsphingosine and acyl-CoA. J. Biol. Chem. 286, 25352-25362
19. Wu, B.X., Zeidan, Y.H., and Hannun, Y.A. (2009) Downregulation of neutral ceramidase by gemcitabine: Implications for cell cycle regulation. Biochim. Biophys. Acta 1791, 730-739
20. Tanaka, K., Tamiya-Koizumi, K., Hagiwara, K., Ito, H., Takagi, A., Kojima, T., Suzuki, M., Iwaki, S., Fujii, S., Nakamura, M., Banno, Y., Kannagi, R., Tsurumi, T., Kyogashima, M., and Murate, T. (2012) Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells. J. Biochem. 151, 611-620
21. Uchida, Y., Houben, E., Park, K., Douangpanya, S., Lee, Y.M., Wu, B. X., Hannun, Y. A., Radin, N. S., Elias, P. M., and Holleran, W. M. (2010) Hydrolytic pathway protects against ceramide-induced apoptosis in keratinocytes exposed to UVB. J. Invest. Dermatol. 130, 2472-2480
22. Osawa, Y., Uchinami, H., Bielawski, J., Schwabe, R. F., Hannun, Y. A., and Brenner, D.A. (2005) Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha. J. Biol. Chem. 280, 27879-27887
23. Kono, M., Dreier, J. L., Ellis, J. M., Allende, M. L., Kalkofen, D. N., Sanders, K. M., Bielawski, J., Bielawska, A., Hannun, Y. A., and Proia, R. L. (2006) Neutral ceramidase encoded by the Asah2 gene is essential for the intestinal degradation of sphingolipids. J. Biol. Chem. 281, 7324-7331
24. Bielawski, J., Pierce, J. S., Snider, J., Rembiesa, B., Szulc, Z. M., and Bielawska, A. (2010) Sphingolipid analysis by high performance liquid chromatography-tandemmass spectrometry (HPLC-MS/MS). Adv. Exp. Med. Biol. 688, 46-59
25. Hernández-Corbacho, M. J., Canals, D., Adada, M.M., Liu, M., Senkal, C. E., Yi, J. K., Mao, C., Luberto, C., Hannun, Y. A., and Obeid, L. M. (2015) Tumor necrosis factor-α (TNFα)-induced ceramide generation via ceramide synthases regulates loss of focal adhesion kinase (FAK) and programmed cell death. J. Biol. Chem. 290, 25356-25373
26. Garzotto, M., White-Jones, M., Jiang, Y., Ehleiter, D., Liao, W. C., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. (1998) 12-Otetradecanoylphorbol-13-acetate-induced apoptosis in LNCaP cells is mediated through ceramide synthase. Cancer Res. 58, 2260-2264
27. Gandy, K. A., Canals, D., Adada, M., Wada, M., Roddy, P., Snider, A. J., Hannun, Y. A., and Obeid, L. M. (2013) Sphingosine 1-phosphate induces filopodia formation through S1PR2 activation of ERM proteins. Biochem. J. 449, 661-672
28. Kim, J. H., Alfieri, A. A., Kim, S. H., and Young, C. W. (1986) Potentiation of radiation effects on two murine tumors by lonidamine. Cancer Res. 46, 1120-1123
29. Bird, R. P. (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37, 147-151
30. Krutovskikh, V. A., and Turusov, V. S. (1994) Tumours of the intestines. IARC Sci. Publ. 111, 195-221
31. Usta, J., El Bawab, S., Roddy, P., Szulc, Z.M., Yusuf, Hannun, A., and Bielawska, A. (2001) Structural requirements of ceramide and sphingosine based inhibitors of mitochondrial ceramidase. Biochemistry 40, 9657-9668
32. Hannun, Y. A., and Obeid, L. M. (2008) Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9, 139-150
33. Pattingre, S., Bauvy, C., Levade, T., Levine, B., and Codogno, P. (2009) Ceramide-induced autophagy: to junk or to protect cells? Autophagy 5, 558-560
34. Blay, J., and Brown, K. D. (1985) Functional receptors for epidermal growth factor in an epithelial-cell line derived from the rat small intestine. Biochem. J. 225, 85-94
35. Mizushima, N., and Yoshimori, T. (2007) How to interpret LC3 immunoblotting. Autophagy 3, 542-545
36. Kung, C. P., Budina, A., Balaburski, G., Bergenstock, M. K., and Murphy, M. (2011) Autophagy in tumor suppression and cancer therapy. Crit. Rev. Eukaryot. Gene Expr. 21, 71-100
37. Venable, M. E., Lee, J. Y., Smyth, M. J., Bielawska, A., and Obeid, L.M. (1995) Role of ceramide in cellular senescence. J. Biol. Chem. 270, 30701-30708
38. Venable, M. E., and Yin, X. (2009) Ceramide induces endothelial cell senescence. Cell Biochem. Funct. 27, 547-551
39. Castro, M. E., Ferrer, I., Cascón, A., Guijarro, M. V., Lleonart, M., Ramóny Cajal, S., Leal, J. F., Robledo, M., and Carnero, A. (2008) PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis 29, 491-499
40. Kraveka, J. M., Li, L., Bielawski, J., Obeid, L. M., and Ogretmen, B. (2003) Involvement of endogenous ceramide in the inhibition of telomerase activity and induction of morphologic differentiation in response to all-trans-retinoic acid in human neuroblastoma cells. Arch. Biochem. Biophys. 419, 110-119
41. Johnson, R. L., and Fleet, J. C. (2013) Animal models of colorectal cancer. Cancer Metastasis Rev. 32, 39-61
42. Pretlow, T. P., and Pretlow, T. G. (2005) Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim. Biophys. Acta 1756, 83-96
43. Rosenberg, D. W., Giardina, C., and Tanaka, T. (2009) Mousemodels for the study of colon carcinogenesis. Carcinogenesis 30, 183-196
44. Tai, C. J., Chang, C. C., Jiang, M. C., Yeh, C. M., Su, T. C., Wu, P. R., Chen, C. J., Yeh, K. T., Lin, S. H., and Chen, H. C. (2012) Clinical-pathological correlation of K-Rasmutation and ERK phosphorylation in colorectal cancer. Pol. J. Pathol. 63, 93-100
45. Brabletz, T., Herrmann, K., Jung, A., Faller, G., and Kirchner, T. (2000) Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am. J. Pathol. 156, 865-870
46. Selzner, M., Bielawska, A., Morse, M. A., Rüdiger, H. A., Sindram, D., Hannun, Y. A., and Clavien, P. A. (2001) Induction of apoptotic cell death and prevention of tumor growth by ceramide analogues in metastatic human colon cancer. Cancer Res. 61, 1233-1240
47. Dahm, F., Bielawska, A., Nocito, A., Georgiev, P., Szulc, Z. M., Bielawski, J., Jochum, W., Dindo, D., Hannun, Y. A., and Clavien, P. A. (2008) Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice. Br. J. Cancer 98, 98-105
48. Chen, Y., Zhang, P., Xu, S. C., Yang, L., Voss, U., Ekblad, E., Wu, Y., Min, Y., Hertervig, E., Nilsson, Å., and Duan, R. D. (2015) Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice. Mol. Cancer Ther. 14, 259-267
49. Kohno, M., Momoi, M., Oo, M. L., Paik, J. H., Lee, Y. M., Venkataraman, K., Ai, Y., Ristimaki, A. P., Fyrst, H., Sano, H., Rosenberg, D., Saba, J.D., Proia, R.L., and Hla, T. (2006) Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation. Mol. Cell. Biol. 26, 7211-7223
50. Degagné, E., Pandurangan, A., Bandhuvula, P., Kumar, A., Eltanawy, A., Zhang, M., Yoshinaga, Y., Nefedov, M., de Jong, P. J., Fong, L. G., Young, S. G., Bittman, R., Ahmedi, Y., and Saba, J. D. (2014) Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated microRNAs. J. Clin. Invest. 124, 5368-5384
51. Liang, J., Nagahashi, M., Kim, E. Y., Harikumar, K. B., Yamada, A., Huang, W. C., Hait, N. C., Allegood, J. C., Price, M. M., Avni, D., Takabe, K., Kordula, T., Milstien, S., and Spiegel, S. (2013) Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell 23, 107-120
52. ElBawab, S., Bielawska, A., and Hannun, Y.A. (1999) Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain. J. Biol. Chem. 274, 27948-27955
53. Franzen, R., Pautz, A., Bräutigam, L., Geisslinger, G., Pfeilschifter, J., and Huwiler, A. (2001) Interleukin-1beta induces chronic activation and de novo synthesis of neutral ceramidase in renal mesangial cells. J. Biol. Chem. 276, 35382-35389
54. Huwiler, A., Pfeilschifter, J., and van den Bosch, H. (1999) Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells. J. Biol. Chem. 274, 7190-7195
55. Franzen, R., Fabbro, D., Aschrafi, A., Pfeilschifter, J., and Huwiler, A. (2002) Nitric oxide induces degradation of the neutral ceramidase in rat renalmesangial cells and is counterregulated by protein kinase C. J. Biol. Chem. 277, 46184-46190
56. Voelkel-Johnson, C., Hannun, Y. A., and El-Zawahry, A. (2005) Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein. Mol. Cancer Ther. 4, 1320-1327
57. White-Gilbertson, S., Mullen, T., Senkal, C., Lu, P., Ogretmen, B., Obeid, L., and Voelkel-Johnson, C. (2009) Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 28, 1132-1141
58. Wargovich, M. J., Brown, V. R., and Morris, J. (2010) Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer. Cancers (Basel) 2, 1705-1716
59. Marchesini, N., Jones, J. A., and Hannun, Y. A. (2007) Confluence induced threonine41/serine45 phospho-beta-catenin dephosphorylation via ceramide-mediated activation of PP1cgamma. Biochim. Biophys. Acta 1771, 1418-1428
60. Schmelz, E.M., Roberts, P.C., Kustin, E.M., Lemonnier, L.A., Sullards, M. C., Dillehay, D. L., and Merrill, A. H., Jr. (2001) Modulation of intracellular beta-catenin localization and intestinal tumorigenesis in vivo and in vitro by sphingolipids. Cancer Res. 61, 6723-6729
61. Verma, U.N., Surabhi, R.M., Schmaltieg, A., Becerra, C., and Gaynor, R. B. (2003) Small interfering RNAs directed against beta-catenin inhibit the invitro and invivo growth of coloncancer cells. Clin. Cancer Res. 9, 1291-1300
62. Roh, H., Green, D. W., Boswell, C. B., Pippin, J. A., and Drebin, J. A. (2001) Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells. Cancer Res. 61, 6563-6568
63. Green, D. W., Roh, H., Pippin, J. A., and Drebin, J. A. (2001) Betacatenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts. J. Surg. Res. 101, 16-20
64. Morad, S. A., and Cabot, M. C. (2013) Ceramide-orchestrated signalling in cancer cells. Nat. Rev. Cancer 13, 51-65